BCL6 and chronic myelogenous leukemia, BCR-ABL1 positive: However, BCL6, a downstream target of PI3K/Akt/FOXO pathway, has been involved in CML-initiating cell maintenance, since BCL6-dependent repression of Arf and p53 is required for colony formation in vitro, and tumor initiation in vivo.